Sustainability Report

Overview

The report describes Imexpharm's 2024 growth, including gross revenue of VND 2,512.8 billion, total energy consumption of 59,606,649 MJ, and quantified Scope 1 and Scope 2 emissions. It also highlights workforce development, gender equality, occupational safety, and community programs, including VND 755 million in scholarships supporting over 220 students.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services